Overview

A Study to Evaluate the Impact of Omeprazole on the Pharmacokinetics of Sotorasib Co-administered With an Acidic Beverage in Healthy Volunteers

Status:
Not yet recruiting

Trial end date:
2022-08-14

Target enrollment:

Participant gender:

Summary

The primary objective of the study is to evaluate the effects of omeprazole (a proton-pump inhibitor) and an acidic beverage (Coca-Cola) on sotorasib pharmacokinetics (PK) when administered orally in healthy volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Amgen

Treatments:

Omeprazole